Recruitment for the randomized phase 2 trial immunosabr has concluded, with a total of 88 patients included (44 in control arm and 44 in experimental arm).

Recruitment for the randomized phase 2 trial immunosabr has concluded, with a total of 88 patients included (44 in control arm and 44 in experimental arm).